What Is Austedo?
Austedo is a prescription medication that contains the active ingredient called deutetrabenazine. The Foods and Drugs Administration has approved its use for treating cholera linked to Huntington’s disease and tardive dyskinesia. Austedo is a type of selective vesicular monoamine transporter 2, which works by lowering the dopamine level in the body. This medication is available in the form of tablets with 3 strength options: 6 milligrams, 9 milligrams, and 12 milligrams. There is currently no generic version.
The US Foods and Drugs Administration has approved the use of Austedo for the following conditions:
– Tardive dyskinesia: This condition affects the nervous system and leads to uncontrolled movements in different parts of the body, such as the upper body, tongue, lips, and face. It typically occurs in those with bipolar disorder, schizophrenia, or those who are taking antipsychotic drugs for an extended period.
– Chorea in those with Huntington’s disease: This condition leads to unexpected involuntary movements of the muscles.
Scientists do not understand how Austedo exactly works to treat these conditions. It is believed that the medication helps restore some chemical balances and thus reduces involuntary movements.